pubs.acs.org/jceda8/artic...
#chemEd
#chemEd
It was great to connect with so many researchers from different disciplines.
#BioMembrOS #artificialrespiration #HorizonEU #EUProject #membranetechnology #biomedicalengineering
It was great to connect with so many researchers from different disciplines.
#BioMembrOS #artificialrespiration #HorizonEU #EUProject #membranetechnology #biomedicalengineering
Oracy in Chemistry Education offers a thorough account of how purposeful talk supports thinking, learning & doing across educational levels.
#RSCBooks #ChemEd
Get your copy here: ccdc-info.com/4BFMSGa
#ChemSky #ChemEd 🥽
Get your copy here: ccdc-info.com/4BFMSGa
#ChemSky #ChemEd 🥽
🔖 Alchemy from @kitchapman.bsky.social
🔖 Materials chemistry from @markmiodownik.bsky.social
🔖 An award-winning novel by Elizabeth Acevedo
Plus 30 more recommendations from teachers and RSC Education staff: edu.rsc.org/feature/eics...
#sciteachuk #chemed
🔖 Alchemy from @kitchapman.bsky.social
🔖 Materials chemistry from @markmiodownik.bsky.social
🔖 An award-winning novel by Elizabeth Acevedo
Plus 30 more recommendations from teachers and RSC Education staff: edu.rsc.org/feature/eics...
#sciteachuk #chemed
library.thecapitolforum.com/docs/9yku2dk...
#$CHE
library.thecapitolforum.com/docs/9yku2dk...
#$CHE
50 filings · 23 HIGH · 27 MEDIUM
Across 50 filings for the Mid-Market Digest (US SEC, 2026-10-29 morning session), the dominant theme is divergence: strong headline earnings (Cullen/Frost, UMB, Chemed, L3Harris...
#StockMarket #FinancialDisclosure #SEC
🧵 See Thread ↓
50 filings · 23 HIGH · 27 MEDIUM
Across 50 filings for the Mid-Market Digest (US SEC, 2026-10-29 morning session), the dominant theme is divergence: strong headline earnings (Cullen/Frost, UMB, Chemed, L3Harris...
#StockMarket #FinancialDisclosure #SEC
🧵 See Thread ↓
Chemed Corporation reported Q3 2026 revenue of $690.9M, up 10.6% YoY from $624.9M, and net income of $71.6M, up 11.5% from $64.2M. Diluted EPS rose to $5.45 from $4.46 (+22.2%), aided by a 9.3% reduction in weighted diluted shares.
🧵 continued ↓
Chemed Corporation reported Q3 2026 revenue of $690.9M, up 10.6% YoY from $624.9M, and net income of $71.6M, up 11.5% from $64.2M. Diluted EPS rose to $5.45 from $4.46 (+22.2%), aided by a 9.3% reduction in weighted diluted shares.
🧵 continued ↓
https://www.stocktitan.net/news/CHE/chemed-reports-third-quarter-2026-ow5t0zb3q5wx.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/CHE/chemed-reports-third-quarter-2026-ow5t0zb3q5wx.html?utm_source=stocktitan-bluesky&utm_medium=social
library.thecapitolforum.com/docs/9y1xem2...
#$CHE
library.thecapitolforum.com/docs/9y1xem2...
#$CHE
On October 27, 2026, Chemed Corporation issued a press release announcing its financial results for the quarter ended September 30, 2026. A copy of the release is furnished herewith as Exhibit 99. Item 9.01 Financial Statements and Exhibits d) Exhibit (99) Registrant’s press release dated ...
On October 27, 2026, Chemed Corporation issued a press release announcing its financial results for the quarter ended September 30, 2026. A copy of the release is furnished herewith as Exhibit 99. Item 9.01 Financial Statements and Exhibits d) Exhibit (99) Registrant’s press release dated ...